10 Comments
 

This is interesting - hadn't thought about this. Could affect internationals relocating for sure. Curious to hear what others say.

 
Most Helpful

The corona virus may have the following impacts on MBA programs:

  • Reduce international travel and study.
  • Reduce attendance at conferences and event.
  • Perhaps move more classes online.

More long-term, here's what I see in my crystal ball:

  • perhaps more long-term use of online instruction if people like the emergency measure.
  • If it takes a while to develop a vaccine, reduced international study programs and conferences.
  • More difficulty for int'l students to get into the U.S.

Most importantly, if the virus continues to hurt the global economy and it sinks into recession, then application volume will increase as young professionals see less opportunity on the job or increased layoffs. They may also feel that two years of b-school is a great place to ride out the economic storm while improving their skills and advancing their career.

Combine this development with the increasing number of schools that have STEM designation, and next year will reverse the declining application volume trend that U.S. MBA programs have experienced over the last 3 years. How far down the MBA food chain/rankings this will go? Sorry, my crystal ball is too cloudy on that one.

Linda Abraham President, Accepted | Contact Me | Admissions Consulting
 

Still the same? I figure MBA market will be out this year. US govt fucking it up - US bschools wont see many admissions and more deferrals- also VISA issue would be a problem , plus the issue of safety - who would go overseas when his/her country is more safe iimore

 

This.

US embassies are no longer working on or issuing non-essential visa. From March 20 for the foreseeable future.

Source: https://travel.state.gov/content/travel/en/News/visas-news/suspension-o…

Therefore international students won't be able to obtain relevant visa and also can no longer travel. Travel itself is disrupted to almost all destinations, so even a visa might not help.

 

Anything possible but I think the default expectation has to be a solid no.

Both the severity (mortality rate) and spread rate (r-naught) have been overstated initially and are coming down. A month ago, people said r-naught of 4+ and mortality as high as 10%. New estimates are r-naught of 1.52 and mortality of 2%. I've been talking to some of the sharper medical research folks and my best guess it will still come down further than that . . r-naught gets to the lower-1's in the US very soon, and mortality settles in around 0.5% with heavy skew to older folks.

Separately, I've noticed another severity measure - ICU rate - coming down too. A week ago the estimate was 20% of all infections, now in Italy we're seeing only 10% and that's supposed to be one of the worse situations.

I'm not a professional but I've been fairly diligent about sourcing the most logical insights from professionals and filtering out poorly supported ones. So I'll call myself a decent messenger at least.

At these numbers, its still about as contagious as flu and 5x as deadly, but for a student population it doesn't seem that it would be dangerous enough to prevent the start of school. Precaution always sounds easy, but people's life plans are important too. Delaying the start has real costs for lots of stakeholders and my gut is that you need something more dangerous than this to delay it

Interested to hear other thoughts.

 

Man . . what a difference a month makes. Obviously, much of what I said above is now obsolete as US hasn't been too successful and we have tons of uncertainty.

I was on conference call Q&A today with one of the leading experts and he said he's still hopeful that schools will be open in the fall but we can't take it for granted. Depends on how things go.

 

Non enim cupiditate earum laborum a. Aliquid animi repellat impedit minima numquam qui ex. Enim ipsa illo maxime dolorum voluptatem numquam.

Accusantium vitae ad dolorem quod. Eos in rem recusandae laborum laboriosam et similique necessitatibus.

Voluptatem hic laudantium est voluptas quia omnis. Quam laborum commodi ipsam eaque sed pariatur. Numquam quisquam similique tenetur consequatur. Ad architecto dicta et aut.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”